NCT03354650 is a clinical trial of blood culture in Neonatal SEPSIS, sponsored by Assiut University.

Who is sponsoring NCT03354650?

NCT03354650 is sponsored by Assiut University.

What drugs are being tested in NCT03354650?

Interventions in NCT03354650: blood culture.

What condition does NCT03354650 study?

NCT03354650 studies Neonatal SEPSIS.

Is NCT03354650 still recruiting?

NCT03354650 is currently status unknown. Last updated 5 December 2017.

Last reviewed 2017-12-05 · How we verify

NCT03354650

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Epidemiology of Neonatal Sepsis in Neonatal Intensive Care Unit in Assiut University Children Hospital

Status unknown Last updated 5 December 2017

What this trial tests

trial testing blood culture in Neonatal SEPSIS in 100 participants. Status unknown.

Timeline

1 January 2018

Primary endpoint
1 January 2019

1 July 2019

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 January 2018
Primary completion	1 January 2019
Estimated completion	1 July 2019

Drugs / interventions tested

blood culture

Conditions studied

Neonatal SEPSIS — all drugs for Neonatal SEPSIS →

Sponsor

Assiut University

Who can join

Under 4 Weeks, any sex, with Neonatal SEPSIS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Neonatal sepsis is an important cause of morbidity and mortality in the pediatric age group . It is one of the leading causes of death in the first 28 days of life both in the developed and developing countries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of blood culture

Trials testing the same drug.

NCT05190861 — Evaluation of Droplet Digital PCR Rapid Detection Method and Precise Diagnosis and Treatment for Suspected Sepsis · NA · completed
NCT03896880 — Detection of Bloodstream Pathogens in Hematological Malignancies · completed
NCT03379948 — Central and Peripheral Venous Catheters Associated Blood Stream Infection in ICU in Assiut University · unknown

Other recruiting trials for Neonatal SEPSIS

Currently open trials in the same condition.

NCT03291496 — Microfluidic Assessment of Clinical Outcomes in Preterm Newborns · active not recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03354650 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 5 December 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03354650.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing